相关实验视频

Updated: Sep 8, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

一种新的方法来提高多种质母细胞瘤治疗疗效:非编码RNA向疗法和辅助方法

Meijun Liu¹, Yuying Wang¹, Xiaoli Chen¹

¹Phenome Research Center, Hong Kong Baptist University, Kowloon, Hong Kong, China.

Clinical epigenetics

|June 21, 2025

概括

重用药物,如迪苏尔菲拉姆和阿司匹林,以及非编码RNA调制,为质母细胞瘤 (GBM) 治疗提供了新的希望. 这些辅助疗法旨在改善这种致命的大脑瘤患者的治疗结果.

科学领域:

神经瘤学神经瘤学
分子生物学分子生物学
药物发现药物发现药物发现

背景情况:

多形质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤.
目前使用泰莫索洛米德 (TMZ) 的标准治疗限制了长期存活率.
迫切需要有效的辅助疗法来改善GBM治疗结果.

研究的目的:

审查质母细胞瘤的新疗法策略.
探索药物重定位和非编码RNA (ncRNA) 调制在GBM治疗中的潜力.
突出结合疗法如何提高疗效和特异性.

主要方法:

对针对GBM的药物重新定位的最新研究的审查,包括temozolomide (TMZ),disulfiram (DSF) 和阿司匹林.
研究基因素脱乙酶抑制剂及其在调节微RNA (miRNA) 和长非编码RNA (lncRNA) 等非编码RNA (ncRNA) 中的作用.
探索像cuproptosis这样的新兴概念,以了解瘤细胞死亡.

主要成果:

迪苏尔菲拉姆 (DSF) 和阿司匹林显示出作为用于GBM治疗的重新定位药物的承诺.
非编码RNA (ncRNA) 调制,包括miRNAs和lncRNAs,可以提高治疗疗效和向.
将传统疗法与ncRNA调制策略相结合,可以提高治疗的有效性.

结论:

非编码RNAs (ncRNAs) 代表了质母细胞瘤的有前途的新型治疗点.
重用药物,如temozolomide (TMZ),disulfiram (DSF) 和阿司匹林可以提高GBM治疗的疗效.
结合药物辅助疗法和ncRNA调制的综合方法为管理GBM提供了创新的策略.

关键词:

亚司匹林是一种阿司匹林.这种疾病叫做cuproptosis.迪苏尔菲拉姆 (Disulfiram) 是一种质母细胞瘤多形没有编码的RNA.泰莫佐洛米德 (Temozolomide) 是一种一种

更多相关视频

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...